Downing Street on Monday announced that Prime Minister Boris Johnson is well, but if he were to fall ill in the coronavirus pandemic, foreign secretary
Gilead Sciences Inc’s experimental drug remdesivir, seen as one of the more promising potential treatments for the coronavirus, on Monday received the orphan drug designation